通心络对急性心肌梗死保守治疗患者疗效观察

Clinic Observation of Tongxinluo Capsule in Conservative Treatment of Patients with AMI

目的:观察通心络胶囊对急性心肌梗死(AMI)未接受经皮冠状动脉介入治疗(PCI)或溶栓治疗后患者的疗效。方法:对我院收治的ST段抬高未实施PCI或溶栓治疗的AMI患者,随机分为常规药物治疗作为对照组(20例)和同时加服用通心络胶囊的治疗组(20例)。于发病后一月内观察再发心绞痛、急性心血管事件、左室射血分数(LVEF)改变。结果:通心络组心功能改善较对照组明显,通心络组再发心绞痛及急性心血管事件较对照组明显减少。结论:通心络对急性心肌梗死保守治疗患者不仅减少心绞痛发作及急性心血管事件的发生而且可改善心功能。

Objecive： To obeserve the effect of Tongxinluo（TXL） capsule in the patients with AMI. Methods： 40 patients with AM/were divided randomly into two groups： TXL group（n=20）treated with TXL and western drugs; control group（n=20） treated with western drugs alone. The symptom of angina cordis, acute cardiovascular events, LVEF were observed before and after treatment. Results： The LVEF of TXL group were improved. The incidence of angina cordis,acute cardiovascular events in TXL group were lower than those in the control group （P〈0.01）. Conculsion： Tongxinluo capsule could not only decrease the symptom of angina cordis,acute cardiovascular events and but also improve the LVEF in the conservative treatment of the patients with AMI.